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Abstract
Background: Phytanic acid produced in ruminants from chlorophyll may have preventive effects on the metabolic
syndrome, partly due to its reported RXR and PPAR- a agonist activity. Milk from cows fed increased levels of
green plant material, contains increased phytanic acid concentrations, but it is unknown to what extent minor
increases in phytanic acid content in dairy fat leads to higher circulating levels of phytanic acid in plasma of the
consumers.
Objective: To investigate if cow feeding regimes affects concentration of plasma phytanic acid and risk markers of
the metabolic syndrome in human.
Design: In a double-blind, randomized, 4 wk, parallel intervention study 14 healthy young subjects were given 45
g milk fat/d from test butter and cheese with 0.24 wt% phytanic acid or a control diet with 0.13 wt% phytanic
acid. Difference in phytanic acid was obtained by feeding roughage with low or high content of chlorophyll.
Results: There tended to be a difference in plasma phytanic acid (P = 0.0730) concentration after the dietary
intervention. Plasma phytanic acid increased significantly within both groups with the highest increase in control
group (24%) compared to phytanic acid group (15%). There were no significant effects of phytanic acid on risk
markers for the metabolic syndrome.
Conclusions: The results indicate that increased intake of dairy fat modify the plasma phytanic acid concentration,
regardless of cows feeding regime and the minor difference in dietary phytanic acid. Whether the phytanic acid
has potential to affects the risk markers of the metabolic syndrome in human still remain to be elucidated.
Trial Registration: ClinicalTrials.gov: NCT01343576
Keywords: Phytanic acid, cow-feeding regime, absorption, fatty acid, total cholesterol, LDL cholesterol, HDL choles-
terol, C-reactive protein, insulin, glucose
Background
Phytanic acid is a multi branched-chain fatty acid
formed through the metabolism of phytol, which is
released from the chlorophyll molecule in the rumen of
ruminant animals [1]. Hence, dairy-products, ruminant
meat and also some marine fats are the only major diet-
ary sources of phytanic acid or its metabolic precursor,
phytol [2]. Dietary intake of phytanic acid have been
suggested to be involved in both health- and disease
promoting processes, thus some researchers have sug-
gested that it can prevent diabetes and metabolic dis-
eases, while others have suggested that it promotes
development of prostate cancer [3,4].
The potential health-promoting properties is based on
the fact that animal and in vitro studies have shown
that phytanic acid might have preventive effects on
metabolic dysfunctions, since it in animal studies
increase expression of genes involved in fatty acid oxida-
tion, enhance glucose uptake and metabolism in hepato-
cyte and potentially reduce metabolic efficacy through
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increased differentiation of brown adipocyte differentia-
tion and expression of uncoupling protein-1 [5-7].
These effects have partly been explained by the PPAR
and RXR agonist activity of phytanic acid [6,8-10].
Hence, phytanic acid may be an interesting, though so
far overlooked, bioactive FA in dairy products with
potential positive effects on metabolic function. How-
ever, the suggested involvement of phytanic acid in
development of prostate cancer also needs to be taken
into consideration. To be able to evaluate the potential
risks and advantages of a dietary intake of phytanic acid,
we need more data on how intake of phytanic acid con-
taining foodstuffs affects levels of phytanic acid, as well
as data on effects on metabolic markers in humans.
Although earlier observational studies have found a sig-
nificant correlation between dairy fat intake and plasma
levels of phytanic acid [3,11,12] this is to over knowl-
edge, the first controlled human intervention study in
which the relation between dairy fat intake and plasma
phytanic acid are directly established.
It is well known that the FA composition of milk fat is
markedly influenced by the diet, especially by the
amount and FA profile of fat in the cattle fodder
[13-16]. Since phytanic acid is formed from metabolites
of chlorophyll degradation, the content in milk fat is
strongly dependent on the amount of chlorophyll-con-
taining material in the feed [17,18], and will also change
over the year depending on the content of green plant
material in the cows diet. A study has shown that the
phytanic acid concentration in milk fat increased from
0.15 mass% to 0.45 mass%, in cows fed grass only com-
pared to a group fed a mixture of rye grass and maize
silage [18] and it was recently shown that the concentra-
tion of phytanic acid is higher in organic than conven-
tional dairy products [19].
In this study the test fat was made from milk from
one herd divided into two groups that were fed either
“green” silage aiming after a moderate content of phyta-
nic acid (0.24 wt%) and “yellow” silage aiming after a
low content of phytanic acid (0.13 wt%). Thus, we have
investigated how the intake of two different butter and
cheese-types, affect plasma phytanic acid concentration
in humans. In addition, we investigate if intake of milk
fat from the green fed cows, affects the risk markers of
the metabolic syndrome differently from milk fat from
cows fed predominantly non-green feed.
Subjects and Methods
Study design
We conducted a 4 week, double-blind, randomized, par-
allel intervention study. In the intervention period sub-
jects were supplied with diets that differed in FA
composition, especially phytanic acid, by the Depart-
ment of Human Nutrition. Participants were stratified
according to baseline phytanic acid concentration in
plasma and sex into two treatment groups receiving
either a diet with a higher content of phytanic acid, phy-
tanic acid group, than the control diet with a low con-
tent of phytanic acid, control group. We assessed all
outcome variables at the start and end of the interven-
tion period.
Subjects
Male and female subjects, age 20 to 42, were recruited
by advertising in local newspapers. The baseline charac-
teristics of the 14 subjects who completed the study
were not different between the two groups (Table 1).
Exclusion criteria were: BMI > 30 kg/m2, current or pre-
vious chronic disease, regular use of medication, or drug
and alcohol abuse. All participants were apparently
healthy as indicated by a medical and lifestyle question-
naire. They all agreed to refrain from taking any dietary
supplements, from donating blood 2 months before and
during the study, and from taking any medication that
might interfere with study measurements. All subjects
were instructed to maintain the same level of physical
activity throughout the study. The subjects completed a
3-day weighed-food record before the intervention and
after two weeks of intervention, in order to assess
potential differences in dietary intake between the
groups before and during the intervention. All records
were coded before being evaluated by a clinical dietician,
who also calculated energy intake and dietary composi-
tion using a national database (Dankost; National Food
Agenty, Søborg, Denmark). Mean habitual energy
intakes were 10.3 MJ/d (range: 6.7-15 MJ/d); 30.9%
Table 1 Baseline characteristics for the 14 healthy
subjects participating in the 4 week intervention1
Treatment
Control group
(n = 5)
Phytanic acid group
(n = 9)
Women, n 2 6
Age, y 31.6 ± 10.3 (20-42) 28.3 ± 5.2 (21-36)
Height, cm 174.6 ± 12.8 (158-190) 171.5 ± 6.9 (162.5-181.5)
Weight, kg 68.7 ± 10.9 (56.1-80.25) 65.5 ± 9.5 (54.20-82.95)
BMI, kg/m2 22.4 ± 1.7 (20.36-24.5) 22.2 ± 2.1 (19.7-26.2)
Phytanic acid, μM 3.35 ± 1.49 (1.75-5.41) 2.93 ± 0.85 (1.89-4.12)
Glucose, mmol/L 5.53 ± 0.6 (5.11-6.58) 5.29 ± 0.33 (4.81-5.88)
Insulin, pmol/L 22.68 ± 11.88 (7.2-39.1) 29.86 ± 24.58 (7.2-86.6)
TAG, mmol/L 0.76 ± 0.35 (0.44-1.31) 0.88 ± 0.22 (0.63-1.32)
Total CH, mmol/L 4.22 ± 1.01 (3.14-5.38) 4.23 ± 0.83 (2.92-5.87)
LDL CH, mmol/L 2.39 ± 0.72 (1.67-3.24) 2.35 ± 0.54 (1.7-3.55)
HDL CH, mmol/L 1.41 ± 0.3 (1.04-1.83) 1.47 ± 0.3 (0.91-1.91)
CRP, mg/L 0.54 ± 0.96 (0,05-2.26) 1.25 ± 0.86 (0.05-2.62)
1Values are mean ± SD; range in parentheses. CPR, C-reactive protein; CH,
Cholesterol; TAG, Triacylglycerol. There were no significant differences
between baseline values in the 2 groups (ANCOVA).
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(23.7-37.8%) of energy was from fat, 15.1% (11.8-18.1%)
was from protein, and 52.2% (42.6-63.7%) was from car-
bohydrates. There were no significant different between
the 2 groups in habitual dietary intake. The protocol
and aims of the study were fully explained (orally and in
writing) to the participants, who gave written informed
consent. The Scientific-Ethical Committees for Copen-
hagen and Frederiksberg approved the research protocol
(H-B-2009-052).
Production of test milk
Milk for the human study was produced by the experi-
mental organic herd at Aarhus University by 56 Danish
Holstein cows with an average daily milk production of
39 kg with 4.46% fat. The cows were divided into two
groups and fed a concentrate consisting of 1:1 mixture of
oat grain and rapeseed cake with 11% fat. This concen-
trate constituted 40% of the diet. The remaining 60% of
the diet consisted of two types of silage, a “green” silage
aiming after a high content of phytanic acid and a “yel-
low” silage aiming after a low content of phytanic acid.
The green silage consisted of a mixture of white clover
grass and alfalfa silage, while the “yellow” silage consisted
of a mixture of corn silage, pea-barley whole crop silage
with a small proportion of white clover grass silage. Feed-
ing of the cows was initiated in November 2008 and milk
was collected from both groups over one week in Febru-
ary. The milk was transported to Thise Dairy (Roslev,
Denmark), where it was processed into butter and cheese.
The higher intake of chlorophyll-containing “green”
silage resulted in a phytanic acid content of 0.24 wt% in
the butter and cheese used for the phytanic acid group
compared to the control group were the “yellow” silage
resulted in a phytanic acid content of 0.13 wt%.
Diets and test fats
During the intervention period part of the diet of the
subjects was replaced with test foods, butter and cheeses
with differing FA compositions, provided by the Depart-
ment of Human Nutrition (Table 2). The test food was
butter and cheese with different concentration of phyta-
nic acid. The fatty acid (FA) composition of the test fats
in butter are presented in table 2. The FA composition
in the two test fats differed only slightly and phytanic
acid differed with 0.11 wt%. The test butter with the
highest content of phytanic acid, also had the highest
content of a-linolenic acid and a lower n-6:n-3 ratio of
about 1.8. This is in agreement with the higher propor-
tion of clover and grass in the green feeding regime.
The butter and cheese were incorporated into buns and
each day during the intervention the subjects were pro-
vided with 3 buns each day; two buns with butter and
one with cheese. The buns contained 4.1 MJ of energy,
with 10 E % from protein, 51 E % from carbohydrates,
and 39 E % from fat (47.9 g). All buns contained 13 g of
butter each; in addition the cheese bun also contained
32 g of 45+ cheese. This amount of butter and cheese
yielded a fat intake from the test diet of 45 g a day (17.5
MJ), which corresponded to approximately 50% of the
maximum recommended daily intake of fat for a subject
with a daily energy requirement of 10 MJ. To avoid
drop outs we decided to use test fat from both butter
and cheese.
Compliance
We used the concentration of pentadecanoic acid (15:0)
in plasma as an indicator of milk fat intake, and thus of
compliance, because 15:0 in serum is considered as a
valid marker for intake of milk fat in humans [20-22]. In
addition dietary records were used to reinforce the diet-
ary advice and strengthen compliance, and the results of
the last records were used in the calculation of dietary
changes during the study.
Blood sampling and analysis
After a 12-h overnight fast, venous blood was collected
before the intervention period (day 1) and at the end of
the intervention (day 28). Blood for FA analysis was col-
lected into tubes containing EDTA, which were kept on
ice, and the samples were centrifuged at 4°C and 2200 ×
g for 15 min.
Table 2 Fatty acid composition of the two test butter
Butter
Control (wt%) Phytanic acid (wt%)
6:0 1.52 1.51
8:0 1.04 1.2
10:0 2.35 2.31
12:0 2.66 2.60
14:0 9.89 10.07
14:1 0.66 0.62
15:0 0.89 0.91
16:0 22.55 24.80
16:1n-7 1.15 1.16
Phytanic acid 0.13 0.24
17:0 0.47 0.50
17:1 0.20 0.20
18:0 15.39 16.00
18:1n-9 trans 2.59 2.25
18:1n-9 cis 25.67 25.17
18:1n-7 0.92 1.31
18:2 n-6 trans 0.49 0.47
18:2 n-6 cis 1.53 1.48
20:0 0.35 0.27
18:3 n-6 0.00 0.00
18:3 n-3 0.48 0.83
≥20:0 0.69 0.29
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All samples were stored at -80°C until the samples
were analysed. All samples were analyzed at the Depart-
ment of Human Nutrition in Copenhagen, except from
the samples of phytanic acid and FA, which were ana-
lyzed at the Technical University of Denmark (DTU).
Blood lipids
We assessed serum LDL and HDL cholesterol by enzy-
matic colorimetric procedure (ABX Pentra LDL Direct
CP and ABX Pentra HDL Direct CP respectively) on
ABX Pentra 400 Chemistry Analyzer (HORIBA ABX,
Montpellier, France). Total cholesterol was assessed and
analyzed by enzymatic photometric procedure (CHOD-
PAP from ABX Pentra Cholesterol CP) on ABX Pentra
400 Chemistry Analyzer (HORIBA ABX, Montpellier,
France). The concentration of TAG was assessed and
analyzed by enzymatic colorimetric procedure (ABX
Pentra Triglycerides CP) on ABX Pentra 400 Chemistry
Analyzer (HORIBA ABX, Montpellier, France).
Fatty acid analysis in lipids and test fats
Total lipids were extracted and analyzed from blood
plasma samples as described by Tholstrup et al [23]
but using TAG C19:0 as internal standard. The test
fats/butters lipids were extracted according to the
method of Folch [24], while preparation of FAME was
performed as described earlier [23]. Response factor
was calculated for methyl esters of phytanic acid and
short-chained fatty acid, based on the response of pal-
mitic acid methyl ester (C16:0). The butter FAME
were separated on a 60-m Supelco SP-2380 column
(Sigma-Aldrich AS, Brøndby, Denmark) in a HP 6890
gas Chromatograph (GC), in split mode using He as
carrier gas. GC settings were: Injector temperature
260°C, split ratio 20: 1, carrier flow 1.2 ml/min, detec-
tor temperature 300°C, air flow in detector 300,0 ml/
min, hydrogen flow 35 ml/min. FAME were separated
using a temperature program starting at 50°C and ris-
ing to 160°C at 15°C/min; this temperature was kept
for 0 min, hereafter the temperature was raised to 182°
C at 1°C/min, and directly the temperature was raised
to 200°C at 10°C/min, and the oven was kept at 200°C
for 15 min before the temperature was raised to 225°C.
The final temperature was kept for 12 min (total run-
time 61.97 min). FAME was identified with authentic
standards, and FA masses were determined based on
the peak areas, compared with the internal standard.
The commercial standard for phytanic acid was par-
tially separated into two peaks, based on the stereoiso-
meric properties of phytanic acid. Both peaks were
identified in the butter, as well as in the plasma. The
separation was however not good enough to quantify
the distribution between the isomers. The phytanic
acid metabolite pristanic acid, was also separated in
the method, this fatty acid did however not reach
above the detection limit in any sample analyzed.
C-reactive protein
Blood for analysis of C-reactive protein was collected
into dry tubes; after samples were centrifuged at 2200 ×
g for 15 min at 20°C. Serum was stored at -80°C until
the samples were analysed. The CRP concentrations
were measured by using latex immunoturbidimetry
(ABX Pentra CRP CP) on ABX Pentra 400 Chemistry
Analyzer (HORIBA ABX, Montpellier, France).
Glucose and Insulin
Blood for analyses of insulin and glucose concentrations
was collected into dry tubes and fluoride citrate respec-
tively; after coagulation, the samples were centrifuged at
2200 × g for 15 min at 20°C. The samples were stored
at -80°C until the there were analysed. Insulin concen-
trations were measured in serum with a chemilumines-
cent immunometric assay on DPC Immulite 1000
(Siemens Medical Solutions Diagnostics, USA). The
intra-assay CV% for insulin was 4.73%. Glucose concen-
tration was measured in plasma and analyzed by enzy-
matic colorimetric procedure (ABX Pentra Glucose HK
CP) on ABX Pentra 400 Clinical Chemistry Analyzer
(HORIBA ABX, Montpellier, France).
Statistical analysis
We used an analysis of covariance (ANCOVA) to com-
pare effect of the two diets. The respective baseline
values were used as covariates, and the analyses were
thus adjusted for the baseline values of each response
variable. When necessary values were log transformed
to normalize the distribution of residual variance and to
obtain variance homogeneity. Statistical tests were per-
formed on the transformed data. Transformation was
necessary to ascertain the concentrations of HDL cho-
lesterol and CRP. SAS statistical software (version 9.2;
SAS institute Inc, Cary, NC) was used for all statistical
analyses. Data describing the characteristics of the parti-
cipants are summarized as mean ± SD, and data on out-
come variables are expressed as least squares (LS)
means ± SEM, adjusted for baseline values. We tested
baseline, age, BMI, phytanic acid and 15:0 for influence
on the results, but all these parameters were not include
in the statistical model, because no influence on results
were found.
Results
Dietary intake and body weight
No significant changes in body weight and habitual diet-
ary intake were observed during and after the interven-
tion period. We excluded 4 food records (2 from each
group) from wk 2 of the intervention from the statistical
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analysis. The distribution (% energy) of protein (P =
0.7180), carbohydrates (P = 0.7157), and total fat (P =
0.0774) did not differ between the groups.
Compliance
The increase of serum15:0 was highest in the control
group in which an average increase of 31% (p < 0.01 vs.
baseline) was observed compared to an increase of 20%
(p < 0.05 vs. baseline) in the phytanic acid group.
Althoug, there was no difference in 15:0 between the
two groups (p = 0,139), the higher increase could indi-
cate a higher consumption of dairy products during the
intervention in the control group.
Blood samples
There tended to be a slight difference in plasma phyta-
nic acid (P = 0.073) between the two groups (Table 3).
The study was not designed to compare baseline and
treatment, however, due to the explorative approach we
considered important to report that the results showed
a significant increase (P < 0.05) of plasma phytanic acid
within both groups. Noteworthingly, the increase was
highest in the control group where an average increase
of 24% was observed compared to an increase of 15% in
the phytanic acid group. There were no effects of the
two treatments on serum total (P = 0.700), LDL (P =
0.274) and HDL (P = 0.475) cholesterol, the triacylgly-
cerol (P = 0.202), CRP (P = 0.4043), serum insulin (P =
0.450) and serum glucose (P = 0.8126) (Table 3).
Discussion
In the current study we investigated to what extent milk
fat from cows fed either “green” or “yellow” silage affects
the concentration of phytanic acid in plasma in healthy
young men and female. The intake of “green” silage
resulted in a phytanic acid content of 0.24 wt% of total
test fat compared to 0.13 wt% in the control group. The
test fat was produced to mimic the variation we have
seen in dairy fat on the Danish market, with low
concentration of phytanic acid during the winter and
highest concentrations late in the grazing season.
The main finding of this study was a significant
increase of plasma phytanic acid within both groups,
regardless of cows feeding regime and test diet phytanic
acid content. The higher increase in plasma phytanic
acid in the control group compare to the phytanic acid
group is opposed to what we have expected. This could
be due to different compliance and/or random differ-
ences in phytanic acid metabolism between the groups.
Since phytanic acid is not produced endogenously in
human [25], the presence in the human body is of exo-
genous origin and ingested from the diet almost exclu-
sively as preformed phytanic acid [26]. The exogenous
origin of phytanic acid in human makes it reasonable to
assume, that the increased concentration of phytanic
acid found after the intervention, was due to an increase
intake in this period. When the concentrations of phyta-
nic acid in serum from 250 healthy humans were ana-
lyzed, it ranged from 0.04 to 11.5 μM [27]. The large
variation probably may illustrate that dietary habit are
determining the concentration of phytanic acid. How-
ever, genetic factors in regard to the efficacy by which
phytanic acid is metabolized may also play a role
[11,18]. Because the test diet substituted only a part of
the habitual diet the phytanic acid content in the test
diets cannot be regarded as being the sole source of
dietary phytanic acid. The low degree of control of
exposure to additional dietary phytanic acid intake
could potentially also have influenced the plasma phyta-
nic acid concentration in the subjects. Indeed, it may
have contributed to the surprisingly high increase of
plasma phytanic acid within the control group compare
to the phytanic acid group. This is supported by the
higher average increase of 15:0 in the control group
which seems to indicate a higher consumption of dairy
products during the intervention compare to the phyta-
nic acid group. In addition, the control group had a
higher mean phytanic acid and 15:0 concentrations at
baseline (data not shown), indicating a higher habitual
dairy fat intake, which also could explain the higher
concentration of phytanic acid after the intervention. A
second source for phytanic acid is marine food, but the
diet protocols of the subjects did not indicate any differ-
ence in habitual intake or during the intervention.
Although we in this study demonstrate that intake of
dairy products with a low concentration of phytanic
acid increase plasma phytanic acid concentrations, there
was unfortunately no significant difference between the
two groups. This may be related to the small number of
subjects, higher baseline phytanic acid levels in the con-
trol group, higher consuming of dairy fat in the non-test
component of the diet in the control group or a combi-
nation of the above. The modest difference in phytanic
Table 3 Effects of the 4-wk dietary intervention1
Treatment
Control group
(n = 5)
Phytanic acid group
(n = 9)
Phytanic acid, μM 4.16 ± 0.24 3.56 ± 0.18
Glucose, mmol/L 5.37 ± 0.10 5.34 ± 0.08
Insulin, pmol/L 33.05 ± 5.69 28.11 ± 4.22
Triacylglycerol, mmol/L 1.15 ± 0.15 0.9 ± 0.11
Total cholesterol, mmol/L 4.46 ± 0.2 4.56 ± 0.15
LDL cholesterol, mmol/L 2.59 ± 0.14 2.82 ± 0.10
HDL cholesterol, mmol/L 1.28 ± 1.10 1.41 ± 1.07
CRP, mg/L 0.26 ± 2.05 0.58 ± 1.77
1 All values are LSmeans ± SEM. CRP, C-reactive protein. ANCOVA; baseline
values were used as covariates.
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acid concentration in the test diets may not be consid-
ered to be very high but the differences are relevant
since it is similar to the seasonal variation occurring in
Danish dairy products. The current study does not give
indication of any possible effects of plasma phytanic
acid on the metabolic variables and potential risk of
developing the metabolic syndrome.
Although the two test butters also differed in the n-3/
n-6 ratio, due to a higher content of a-linolenic acid in
the phytanic acid rich butter, we do not consider this
differences relevant for the outcome of the intervention,
since intake of linoleic and a-linolenic acid from the
butters only contributed minimally to the test subjects
total intake of these fatty acids. Thus, intake of the con-
trol butter contributed with only about 675 mg linoleic
and 215 mg a-linolenic acid per day and the phytanic
acid rich butter with the same amount of linoleic acid
but with 380 mg a-linolenic acid. Since a typical daily
Danish intake of polyunsaturated fatty acids for men
and women are 14 and 10 g/day, respectively [28], the
contribution from the test-butters have only marginally
affected the total intake.
In the present study population, the plasma phytanic
acid concentration varied between 1.75 and 6.13 μM.
The EC50 for transactivation of all three RXR - isoforms
by phytanic acid have been determined to be between
2.3 and 4 μM [9,10]. This indicate that plasma phytanic
acid concentration in this study population occur in a
concentration in which it has physiological relevance as
a modulator of RXR-activity. Finally, the issue on the
association between prostate cancer risk and phytanic
acid intake needs to be taken into consideration. It has
been hypothesized that phytanic acid could be asso-
ciated with increased risk of prostate cancer [3]. How-
ever, no conclusive adverse effects of phytanic acid
intake and concentrations within the normal range in
healthy humans have been established and there is no
data in the literature indicating that the modest changes
in phytanic acid that are induced in present study,
would have negative impact on human health [29]
The strengths of our study include its controlled and
randomized design, follow-up of dietary compliance dur-
ing the study, the use of validated dietary marker to
monitor the dairy fat intake, the test fat was modified
from milk originating from dairy cattle from the same
herd, and the differences between the two types of test
fat was obtained through natural reproducible cow feed-
ing regimes. Furthermore the controlled cow feeding
procedure is also considered to be an advantage of the
study design. However, since the feeding regimes were
designed to mimic what is possible to perform in Danish
high-yielding herds, it was not possible to keep the cows
on pure green feeding-regime. It would therefore be
interesting to study the effect of dairy fat that are
derived from cows fed pure green material (e. g. grazing
cows), which would result in substantially higher con-
centration of phytanic acid, as well as other bioactive
fatty acids. Among the limitations were the relatively
high intakes of butter during the intervention. However,
the increase in dietary fat during intervention did not
differ between the two groups, and neither did the body
weight after the intervention. It is also possible that dif-
ference in random habitual dietary habits and compli-
ance such as and higher increase in serum 15:0,
indicating higher dairy intake, in the control group after
the intervention may have affected the results.
It would be relevant to use pure phytanic acid, but
this has not yet been possible due to high costs required
to produce purified synthetic phytanic acid products for
human intervention studies. There is a general lack of
evidence to support the results obtained in the study as
research on phytanic acid effect in human is missing.
Further research must elucidate if increase intake of
dietary phytanic acid might play a part in improving the
metabolic syndrome and increase the risk of prostate
cancer in human.
Conclusion
This study indicate that increased intake of dairy fat
modify the plasma phytanic acid concentration, regard-
less of cows feeding regime and the minor difference in
dietary phytanic acid content after 4 weeks. Further
feeding-studies, in which phytanic acid is used in phy-
siological relevant concentration, is essential before it is
possible to conclude whether increased intake of phyta-
nic acid have preventive effect on the metabolic syn-
drome in human.
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